These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 205164)

  • 1. Plasma lipoproteins and coronary heart disease.
    Scanu AM
    Ann Clin Lab Sci; 1978; 8(2):79-83. PubMed ID: 205164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease].
    Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA
    Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic considerations.
    Miller NE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S190-5. PubMed ID: 6177955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of lipid disorders to coronary heart disease.
    Glueck CJ
    Am J Med; 1983 May; 74(5A):10-4. PubMed ID: 6846376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid measurements for coronary risk assessment: a review.
    Berg LH
    Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 9. Inverse relationship of serum LDL cholesterol and the LDL/HDL cholesterol ratio to liver microsomal enzyme induction in man.
    Luoma PV; Sotaniemi EA; Pelkonen RO
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):173-6. PubMed ID: 6648042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factor hyperlipidemia. Dealing with reality].
    Wolfram G
    MMW Munch Med Wochenschr; 1982 Feb; 124(5):91-2. PubMed ID: 6806637
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.
    Shepherd J; Packard CJ; Patsch JR; Gotto AM; Taunton OD
    J Clin Invest; 1979 May; 63(5):858-67. PubMed ID: 221531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dyslipidemias and coronary disease].
    Douste-Blazy P; Douste-Blazy L
    Ann Biol Clin (Paris); 1986; 44(5):559-64. PubMed ID: 3544979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipoprotein cholesterol and coronary heart disease.
    Misra KP; Suresh S; Balachandran G; Reddy KN; Rao PM; Radhakrishnan T; Shanmugasundaram KR
    J Assoc Physicians India; 1980 Nov; 28(11):399-404. PubMed ID: 7216970
    [No Abstract]   [Full Text] [Related]  

  • 16. Altered metabolism (in vivo and in vitro) of plasma lipoproteins after selective chemical modification of lysine residues of the apoproteins.
    Mahley RW; Innerarity TL; Weisgraber KB; Oh SY
    J Clin Invest; 1979 Sep; 64(3):743-50. PubMed ID: 224077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging problem of plasma lipid changes during antihypertensive therapy.
    Johnson BF
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S213-21. PubMed ID: 6177959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The peculiarities of lipid and protein components of the high- and low-density lipoproteins in patients suffering from coronary atherosclerosis with different number of affected coronary arteries.
    Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaya TI; Polessky VA; Matveeva LS
    Cor Vasa; 1981; 23(4):248-56. PubMed ID: 7297073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the levels and composition of lipoproteins and apolipoproteins of blood plasma in patients with ischemic heart disease after hemosorption].
    Torkhovskaia TI; Khalilov EM; Oleĭnik IA; Kliuchnikova ZhI; Klimov AN
    Kardiologiia; 1989 Oct; 29(10):60-4. PubMed ID: 2615161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.